Detalhe da pesquisa
1.
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
N Engl J Med
; 385(1): 35-45, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192430
2.
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.
Int J Mol Sci
; 24(13)2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445994
3.
Distribution of histopathological features along the colon in microscopic colitis.
Int J Colorectal Dis
; 36(1): 151-159, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920702
4.
Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
Clin Gastroenterol Hepatol
; 17(1): 98-106.e4, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29702300
5.
Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
Gastroenterology
; 146(5): 1222-30.e1-2, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24440672
6.
Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study.
Biol Blood Marrow Transplant
; 18(1): 134-40, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21703973
7.
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.
Gastroenterology
; 140(2): 425-434.e1; quiz e13-4, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21070781
8.
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial.
J Crohns Colitis
; 16(11): 1714-1724, 2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35709376
9.
Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial.
United European Gastroenterol J
; 9(7): 837-847, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34414678
10.
Smoking Status Influences Clinical Outcome in Collagenous Colitis.
J Crohns Colitis
; 10(4): 449-54, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26721941
11.
The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study.
Dig Liver Dis
; 47(2): 144-50, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25483910
12.
Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
Inflamm Bowel Dis
; 16(11): 1947-56, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20310020